Exagen: Q3 Earnings Insights - Exagen (NASDAQ:XGN)

Exagen XGN reported its Q3 earnings results on Wednesday, November 10, 2021 at 04:05 PM.

Here's what investors need to know about the announcement.

Exagen their estimated earnings by 8.7%, reporting an EPS of $-0.42 versus an estimate of $-0.46, which did not surprise analysts.

Revenue was up $1,476,000 from the same period last year.

Last quarter the company beat on EPS by $0.06, which was followed by a 24.59% increase in the share price the next day.

Here's a look at Exagen's past performance:

Quarter	Q2 2021	Q1 2021	Q4 2020	Q3 2020
EPS Estimate	-0.44	-0.47	-0.40	-0.48
EPS Actual	-0.38	-0.48	-0.27	-0.34
Revenue Estimate	11.48M	10.45M	10.76M	8.88M
Revenue Actual	12.77M	10.59M	12.67M	10.78M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.